Tagapan, Letty B.

HRN: 24 43 84  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/16/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/16/2024
01/22/2024
IV INFUSION
1.5gm
Q6
Non Healing Wound
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: